Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in TaxesFree Cash FlowNet Cash FlowNet IncomeShares Issued
Growth Metrics
Income Statement
Others
Ratios

Elite Health Systems (EHSI) Gains from Investment Securities (2016 - 2024)

Elite Health Systems (EHSI) has disclosed Gains from Investment Securities for 13 consecutive years, with $268000.0 as the latest value for Q3 2024.

  • On a quarterly basis, Gains from Investment Securities changed N/A to $268000.0 in Q3 2024 year-over-year; TTM through Sep 2024 was $268000.0, a 14.53% increase, with the full-year FY2023 number at $23000.0, down 89.1% from a year prior.
  • Gains from Investment Securities was $268000.0 for Q3 2024 at Elite Health Systems, up from $23000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $268000.0 in Q3 2024 to a low of -$183000.0 in Q3 2022.
  • A 4-year average of $67800.0 and a median of $27000.0 in 2020 define the central range for Gains from Investment Securities.
  • Biggest YoY gain for Gains from Investment Securities was 653.33% in 2020; the steepest drop was 82.39% in 2020.
  • Elite Health Systems' Gains from Investment Securities stood at $113000.0 in 2020, then soared by 86.73% to $211000.0 in 2022, then crashed by 89.1% to $23000.0 in 2023, then soared by 1065.22% to $268000.0 in 2024.
  • Per Business Quant, the three most recent readings for EHSI's Gains from Investment Securities are $268000.0 (Q3 2024), $23000.0 (Q1 2023), and $211000.0 (Q4 2022).